Literature DB >> 24074662

Retained central venous lines (CVLs) after attempted removal: an 11-year series and literature review.

B K Y Chan1, S N Rupasinghe, I Hennessey, I Peart, C T Baillie.   

Abstract

BACKGROUND: Central venous lines (CVLs) are frequently used in the management of many neonatal and pediatric conditions. Failure to remove the luminal part of the line (retained CVL) is rare. Consequently, there is lack of experience and consensus in its optimal management. AIM: To document the incidence and management of retained CVLs in a tertiary pediatric surgical centre with access to interventional cardiology services. To review the literature and report efficacy/morbidity of attempted extraction of retained CVLs.
METHODS: Children with retained CVLs were identified from departmental morbidity and mortality records over an 11-year period. A literature search was performed in PubMed and Scopus to identify studies reporting retained CVLs (earliest date to 1 January 2012). This was supplemented by scanning bibliographies of retrieved articles.
RESULTS: The 11-year incidence of retained CVL was 0.3% (n=10; median duration in-situ 66.5 {range 47-146} months). The underlying pathology in 8 was cystic fibrosis. Antegrade transfemoral snare retrieval was successful in 6 of 7 attempts. In the remaining 3, a conservative approach was adopted following consultation with the family. None of the 4 with retained CVL developed complications (median follow-up 7.5 {range 1-53} months). The literature describes 38 pediatric index cases (including 10 from the current series). Seventeen (49%) were managed conservatively either intentionally or by default after failed endovascular removal attempt (n=4). No complications directly attributed to retained CVLs have been reported (median follow-up 40 {range 1-120} months). Reported morbidity associated with endovascular retrieval includes: procedural failure 30%, line embolization 8%, and intra-operative thrombo-embolism 8%.
CONCLUSION: Literature regarding management of retained CVLs is anecdotal. Although uncommon, the complication should feature in consent for removal of CVLs. Conservative management carries long-term risks of infection, thrombosis, and even migration, albeit unquantified over a child's lifetime. Endovascular retrieval is feasible with appropriate expertise.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Central venous line; Complications; Endovascular; Fragments; Removal; Retained

Mesh:

Year:  2013        PMID: 24074662     DOI: 10.1016/j.jpedsurg.2013.01.050

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  6 in total

1.  Incidence and outcome of retained Port-A-Cath fragments during removal.

Authors:  Olugbenga Michael Aworanti; Niall Linnane; Farhan Tareen; Alan Mortell
Journal:  Pediatr Surg Int       Date:  2017-06-05       Impact factor: 1.827

2.  Complicated vascular access port removals: incidence, antecedents and avoidance.

Authors:  Warwick J Teague; Dina Fouad; Fraser D Munro; Amanda J McCabe
Journal:  Pediatr Surg Int       Date:  2015-07-30       Impact factor: 1.827

3.  The causes of lower-extremity deep venous thrombosis in the children with cranial diseases.

Authors:  Yan Wang; Wei Liu; Ge Jia; Na Li; Yulong Jia
Journal:  Int J Clin Exp Med       Date:  2015-11-15

Review 4.  Long-term vascular access in differently resourced settings: a review of indications, devices, techniques, and complications.

Authors:  Karen Milford; Dirk von Delft; Nkululeko Majola; Sharon Cox
Journal:  Pediatr Surg Int       Date:  2020-03-21       Impact factor: 1.827

5.  Efficacy and clinical outcome of the port-a-cath in children: a tertiary care-center experience.

Authors:  Osama Bawazir; Elaf Banoon
Journal:  World J Surg Oncol       Date:  2020-06-19       Impact factor: 2.754

6.  Risk factors for unsuccessful removal of central venous access ports implanted in the forearm of adult oncologic patients.

Authors:  Mitsuhiro Kinoshita; Shoichiro Takao; Junichiro Hiraoka; Katsuya Takechi; Yoko Akagawa; Kyosuke Osaki; Norio Ohnishi; Hayato Tani
Journal:  Jpn J Radiol       Date:  2021-11-15       Impact factor: 2.374

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.